#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	748	CRP	633	633	99.37	CRP.l15.c4.ctg.1	1075	37.4	0	.	p	.	0	K29T	NONSYN	85	87	AAG	302	304	ACG	28;29;29	A;C;G	28;29;29	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	748	CRP	633	633	99.37	CRP.l15.c4.ctg.1	1075	37.4	0	.	p	.	0	T209S	NONSYN	625	627	ACT	842	844	TCT	33;32;32	T,A;C;T	32,1;32;32	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	500	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	141	43.4	0	.	n	.	0	T879G	SNP	879	879	T	18	18	G	2	G	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	500	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	141	43.4	0	.	n	.	0	G880A	SNP	880	880	G	19	19	A	2	A	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	500	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	141	43.4	0	.	n	.	0	A888G	SNP	888	888	A	27	27	G	3	G	3	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	500	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	141	43.4	0	.	n	.	0	C897G	SNP	897	897	C	36	36	G	9	G	9	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	500	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	141	43.4	0	.	n	.	0	T898C	SNP	898	898	T	37	37	C	11	C	11	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	500	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	141	43.4	0	.	n	.	0	G906T	SNP	906	906	G	45	45	T	29	T	29	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	500	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	141	43.4	0	.	n	.	0	G908A	SNP	908	908	G	47	47	A	30	A	30	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	500	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	141	43.4	0	.	n	.	0	A918T	SNP	918	918	A	57	57	T	36	T	36	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	500	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	141	43.4	0	.	n	.	0	A943G	SNP	943	943	A	82	82	G	104	G	104	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	500	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c30.ctg.1	141	43.4	0	.	n	.	0	G991T	SNP	991	991	G	130	130	T	50	T	50	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	3244	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1580	107.6	0	.	p	.	0	G409S	NONSYN	1225	1227	GGC	1413	1415	AGC	66;65;66	A,G;G;C	39,27;65;66	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	3244	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1580	107.6	1	SNP	p	R234F	1	.	.	700	702	TTC	888	890	TTC	153;153;148	T;T;C	152;151;148	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	3244	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1580	107.6	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1188	1190	CGT	131;133;133	C;G;T	129;133;131	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	3244	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1580	107.6	0	HET	.	.	.	C261T	.	261	261	C	449	449	C	126	C,T	72,50	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	3244	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1580	107.6	0	HET	.	.	.	T999C	.	999	999	T	1187	1187	T	121	T,C	69,51	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	3244	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1580	107.6	0	HET	.	.	.	T90C	.	90	90	T	278	278	T	75	T,C	54,21	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	667	3244	Escherichia_coli_EF_Tu	1230	1230	99.59	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1580	107.6	0	HET	.	.	.	T180C	.	180	180	T	368	368	T	92	T,C	53,25	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1116	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c17.ctg.1	1747	34.3	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1531	1533	AAA	14;14;13	A;A;A	14;14;13	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1564	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l15.c30.ctg.1	1683	49.7	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1280	1282	GAA	52;52;49	G;A;A	52;52;49	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	294	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	788	20.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	4136	Pasteurella_multocida_16S	1551	133	93.23	Pasteurella_multocida_16S.l15.c30.ctg.2	382	58.3	0	.	n	.	0	C1431A	SNP	1431	1431	C	13	13	A	3	A	2	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	4136	Pasteurella_multocida_16S	1551	133	93.23	Pasteurella_multocida_16S.l15.c30.ctg.2	382	58.3	0	.	n	.	0	C1432A	SNP	1432	1432	C	14	14	A	3	A	2	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	4136	Pasteurella_multocida_16S	1551	133	93.23	Pasteurella_multocida_16S.l15.c30.ctg.2	382	58.3	0	.	n	.	0	A1441G	SNP	1441	1441	A	23	23	G	4	G	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	4136	Pasteurella_multocida_16S	1551	133	93.23	Pasteurella_multocida_16S.l15.c30.ctg.2	382	58.3	0	.	n	.	0	T1464C	SNP	1464	1464	T	46	46	C	36	C	36	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	4136	Pasteurella_multocida_16S	1551	133	93.23	Pasteurella_multocida_16S.l15.c30.ctg.2	382	58.3	0	.	n	.	0	G1473T	SNP	1473	1473	G	55	55	T	99	T	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	4136	Pasteurella_multocida_16S	1551	133	93.23	Pasteurella_multocida_16S.l15.c30.ctg.2	382	58.3	0	.	n	.	0	A1475G	SNP	1475	1475	A	57	57	G	110	G	109	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	528	4136	Pasteurella_multocida_16S	1551	133	93.23	Pasteurella_multocida_16S.l15.c30.ctg.2	382	58.3	0	.	n	.	0	A1548T	SNP	1548	1548	A	130	130	T	78	T	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1218	PmrB_1	1092	1092	99.18	PmrB_1.l15.c4.ctg.1	1464	44.5	0	.	p	.	0	H2R	NONSYN	4	6	CAT	195	197	CGT	34;35;36	C;G;T	34;35;36	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1218	PmrB_1	1092	1092	99.18	PmrB_1.l15.c4.ctg.1	1464	44.5	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1038	1040	GGC	70;69;69	G;G;C	70;69;69	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1816	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	1955	50.0	0	.	p	.	0	R8S	NONSYN	22	24	AGA	187	189	AGC	15;16;16	A;G;C	15;16;16	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1816	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	1955	50.0	0	.	p	.	0	I142L	NONSYN	424	426	ATA	589	591	CTA	46;47;47	C;T,A;A	46;46,1;47	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1816	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	1955	50.0	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1108	1110	CAA	67;65;64	C;A;A	67;65;63	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1816	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	1955	50.0	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1207	1209	GGT	60;58;58	G;G;T	60;58;58	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1816	PmrC	1644	1644	99.15	PmrC.l15.c17.ctg.1	1955	50.0	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1777	1779	GTT	21;20;19	G;T;T	21;20;19	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	596	PmrE	1167	1167	96.92	PmrE.l15.c17.ctg.1	1422	22.2	0	.	p	.	0	A125E	NONSYN	373	375	GCA	556	558	GAA	27;27;28	G;A;A	26;27;28	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	596	PmrE	1167	1167	96.92	PmrE.l15.c17.ctg.1	1422	22.2	0	.	p	.	0	M185T	NONSYN	553	555	ATG	736	738	ACC	8;8;8	A;C;C	8;8;8	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	596	PmrE	1167	1167	96.92	PmrE.l15.c17.ctg.1	1422	22.2	0	.	p	.	0	S225T	NONSYN	673	675	TCC	856	858	ACT	14;13;12	A;C;T	14;13;12	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	596	PmrE	1167	1167	96.92	PmrE.l15.c17.ctg.1	1422	22.2	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1246	1248	ATC	8;8;8	A;T;C	8;8;8	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	912	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1396	35.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	528	102	TEM_1+	858	291	98.63	TEM_1+.l15.c17.ctg.1	313	7.2	0	.	p	.	0	F19L	NONSYN	55	57	TTT	77	79	CTT	17;17;17	C;T;T	17;17;17	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	528	102	TEM_1+	858	291	98.63	TEM_1+.l15.c17.ctg.1	313	7.2	0	.	p	.	0	V82I	NONSYN	244	246	GTT	266	268	ATT	4;4;4	A;T;T	4;4;4	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2916	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3491	44.9	0	.	p	.	0	T85I	NONSYN	253	255	ACC	450	452	ATC	40;41;40	A;T;C	40;41;40	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2916	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3491	44.9	0	.	p	.	0	G549S	NONSYN	1645	1647	GGC	1842	1844	AGC	58;57;57	A;G;C	58;56;57	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2916	acrD	3114	3114	99.07	acrD.l15.c4.ctg.1	3491	44.9	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2163	2165	AAG	22;22;22	A;A;G	22;22;22	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1252	acrE	1158	1158	98.7	acrE.l6.c30.ctg.1	1523	44.2	0	.	p	.	0	A22V	NONSYN	64	66	GCC	246	248	GTC	8;8;9	G;T;C	8;8;9	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1252	acrE	1158	1158	98.7	acrE.l6.c30.ctg.1	1523	44.2	0	.	p	.	0	E115K	NONSYN	343	345	GAA	525	527	AAA	46;49;52	A,G;A;A	44,2;49;49	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1252	acrE	1158	1158	98.7	acrE.l6.c30.ctg.1	1523	44.2	0	.	p	.	0	S269C	NONSYN	805	807	AGC	987	989	TGC	62;60;59	T;G;C	61;60;59	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3190	acrF	3105	3105	98.78	acrF.l6.c4.ctg.1	3479	49.1	0	.	p	.	0	S46trunc	TRUNC	136	136	T	344	344	T	35	T	35	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3190	acrF	3105	3105	98.78	acrF.l6.c4.ctg.1	3479	49.1	0	.	p	.	0	G148D	NONSYN	442	444	GGC	650	652	GAC	55;55;56	G;A;C	54;55;56	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3190	acrF	3105	3105	98.78	acrF.l6.c4.ctg.1	3479	49.1	0	.	p	.	0	F240L	NONSYN	718	720	TTT	926	928	TTA	19;18;18	T;T;A	19;18;18	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3190	acrF	3105	3105	98.78	acrF.l6.c4.ctg.1	3479	49.1	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2003	2005	AAT	55;55;55	A;A;T	55;55;54	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3190	acrF	3105	3105	98.78	acrF.l6.c4.ctg.1	3479	49.1	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2117	2119	AGT	41;44;45	A;G;T	41;44;45	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3190	acrF	3105	3105	98.78	acrF.l6.c4.ctg.1	3479	49.1	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2516	2518	GTG	41;42;42	G;T;G	41;41;41	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3190	acrF	3105	3105	98.78	acrF.l6.c4.ctg.1	3479	49.1	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3071	3073	AAG	40;41;42	A;A;G	40;40;42	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	574	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1046	29.5	1	SNP	p	R45C	0	.	.	133	135	CGC	323	325	CGC	40;39;39	C;G;C	39;39;39	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	588	acrS	663	663	98.79	acrS.l15.c30.ctg.1	934	33.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	165	167	TTC	32;31;30	T;T;C	31;30;30	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	588	acrS	663	663	98.79	acrS.l15.c30.ctg.1	934	33.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	429	431	GGG	44;42;42	G;G;G	44;42;42	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	782	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1151	36.5	0	.	p	.	0	V136L	NONSYN	406	408	GTT	609	611	CTT	53;54;55	C;T;T	53;54;55	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2874	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3053	50.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2059	2061	GCA	72;75;77	G;C;A	72;75;77	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2874	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3053	50.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2320	2322	ACC	68;69;71	A;C;C	65;69;71	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2874	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3053	50.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2629	2631	GCC	43;44;44	G;C;C	43;44;44	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1586	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2366	36.0	0	.	p	.	0	G37A	NONSYN	109	111	GGT	287	289	GCT	10;11;11	G;C;T	10;11;11	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1586	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2366	36.0	0	.	p	.	0	D77E	NONSYN	229	231	GAT	407	409	GAG	9;10;9	G;A;G	9;10;9	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1586	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2366	36.0	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	443	445	TGC	13;13;13	T;G;C	13;13;13	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1586	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2366	36.0	0	.	p	.	0	I150V	NONSYN	448	450	ATT	626	628	GTT	23;25;25	G;T;T	21;25;25	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1586	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2366	36.0	0	.	p	.	0	R200H	NONSYN	598	600	CGC	776	778	CAC	35;33;32	C;A;C	35;33;31	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1586	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2366	36.0	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1061	1063	ATG	59;58;58	A;T;G	59;58;58	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1586	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2366	36.0	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2057	2059	CGC	39;42;44	C;G;C	38;42;44	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	586	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1214	25.7	0	.	p	.	0	S221T	NONSYN	661	663	AGC	870	872	ACC	26;26;27	A;C;C	26;26;27	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	586	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1214	25.7	0	.	p	.	0	P225S	NONSYN	673	675	CCG	882	884	TCG	22;25;25	T;C;G	22;25;25	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	608	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1149	28.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1132	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1595	36.9	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1304	1306	AAA	11;11;11	A;A;A	9;11;11	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1132	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1595	36.9	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1316	1318	GAG	12;12;12	G;A;G	11;9;12	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1132	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1595	36.9	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1322	1324	CAC	15;16;16	C;A;C	14;15;15	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1132	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1595	36.9	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1376	1378	GAG	20;18;19	G;A;G	20;18;19	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1506	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1858	43.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	896	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1149	42.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	816	cysB	975	975	99.38	cysB.l15.c4.ctg.1	1360	32.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1106	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1586	37.5	0	.	p	.	0	W42C	NONSYN	124	126	TGG	327	329	TGT	25;24;25	T;G;T	25;23;24	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1106	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1586	37.5	0	.	p	.	0	I219V	NONSYN	655	657	ATC	858	860	GTC	56;55;55	G;T;C	55;53;55	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	1820	emrB	1539	1539	99.81	emrB.l15.c30.ctg.1	1898	51.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1106	emrD	1191	1191	98.57	emrD.l15.c30.ctg.1	1592	37.2	0	.	p	.	0	G209S	NONSYN	625	627	GGC	846	848	AGC	25;24;24	A;G;C	25;24;24	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	44	emrE_1	333	135	92.59	emrE_1.l15.c30.ctg.1	135	6.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	696	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1447	25.9	0	.	p	.	0	K176R	NONSYN	526	528	AAG	729	731	AGG	23;23;23	A;G;G	23;23;23	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	696	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1447	25.9	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1119	1121	GAC	20;21;21	G;A;C	20;21;21	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	550	emrR	531	531	100.0	emrR.l15.c4.ctg.1	975	30.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1074	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1991	29.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	454	evgA	615	615	99.19	evgA.l15.c4.ctg.1	995	24.5	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	360	362	CTG	29;28;29	C;T;G	29;28;29	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	918	97.28	evgS.l15.c17.ctg.1	1045	20.7	0	.	p	.	0	T38I	NONSYN	112	114	ACA	239	241	ATA	8;8;8	A;T;A	7;8;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	918	97.28	evgS.l15.c17.ctg.1	1045	20.7	0	.	p	.	0	L42V	NONSYN	124	126	CTA	251	253	GTA	5;5;5	G;T;A	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	918	97.28	evgS.l15.c17.ctg.1	1045	20.7	0	.	p	.	0	A93T	NONSYN	277	279	GCG	404	406	ACG	22;22;21	A;C;G	22;22;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	918	97.28	evgS.l15.c17.ctg.1	1045	20.7	0	.	p	.	0	A114E	NONSYN	340	342	GCA	467	469	GAA	21;21;23	G;A;A	21;21;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	918	97.28	evgS.l15.c17.ctg.1	1045	20.7	0	.	p	.	0	T127A	NONSYN	379	381	ACT	506	508	GCT	20;19;19	G;C;T	20;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	918	97.28	evgS.l15.c17.ctg.1	1045	20.7	0	.	p	.	0	N133D	NONSYN	397	399	AAT	524	526	GAT	14;13;12	G;A;T	14;13;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	918	97.28	evgS.l15.c17.ctg.1	1045	20.7	0	.	p	.	0	P162S	NONSYN	484	486	CCA	611	613	TCA	21;21;21	T;C;A	21;21;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	918	97.28	evgS.l15.c17.ctg.1	1045	20.7	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	740	742	CAG	15;15;14	C;A;G	15;15;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	918	97.28	evgS.l15.c17.ctg.1	1045	20.7	0	.	p	.	0	I251V	NONSYN	751	753	ATT	878	880	GTT	14;14;14	G;T;T	14;14;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	918	97.28	evgS.l15.c17.ctg.1	1045	20.7	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1034	1036	GAT	6;6;5	G;A;T	6;6;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2600	36.0	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	197	199	AAA	16;16;16	A;A;A	16;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2600	36.0	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	932	934	CAT	19;17;17	C;A;T	19;17;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2600	36.0	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	986	988	CAT	26;26;26	C;A;T	25;26;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2600	36.0	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1004	1006	AGA	18;18;17	A;G;A	18;18;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2600	36.0	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1019	1021	AAT	20;22;21	A;A;T	20;22;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2600	36.0	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1166	1168	TCC	14;16;16	T;C;C	14;16;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2600	36.0	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1331	1333	ATT	27;27;26	A;T;T	27;27;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2600	36.0	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1352	1354	GAT	26;26;27	G;A;T	26;24;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2600	36.0	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1466	1468	GTT	39;39;38	G;T;T	39;39;38	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2600	36.0	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1751	1753	CAC	44;45;44	C;A;C	44;45;44	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2200	evgS	3594	2490	97.87	evgS.l15.c17.ctg.2	2600	36.0	0	.	p	.	0	D1197N	NONSYN	3589	3591	GAC	2489	2491	AAC	20;21;20	A;A;C	20;21;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	810	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1271	34.2	1	SNP	p	P64H	0	.	.	190	192	CCA	391	393	CCA	69;68;68	C;C;A	69;68;66	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	810	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1271	34.2	1	SNP	p	P64L	0	.	.	190	192	CCA	391	393	CCA	69;68;68	C;C;A	69;68;66	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	810	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1271	34.2	1	SNP	p	P64S	0	.	.	190	192	CCA	391	393	CCA	69;68;68	C;C;A	69;68;66	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	810	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1271	34.2	1	SNP	p	P64R	0	.	.	190	192	CCA	391	393	CCA	69;68;68	C;C;A	69;68;66	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	810	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1271	34.2	1	SNP	p	P64A	0	.	.	190	192	CCA	391	393	CCA	69;68;68	C;C;A	69;68;66	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	490	gadE	528	528	100.0	gadE.l15.c4.ctg.1	922	28.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	166	gadW	729	104	98.08	gadW.l15.c17.ctg.1	104	34.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	166	gadW	729	143	95.8	gadW.l15.c17.ctg.2	143	16.2	0	.	p	.	0	K110N	NONSYN	328	330	AAA	12	14	AAT	5;6;6	A;A;T	5;6;6	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	518	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1069	25.9	0	.	p	.	0	F53L	NONSYN	157	159	TTC	323	325	TTA	32;30;29	T;T;A	32;30;29	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	518	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1069	25.9	0	.	p	.	0	V79I	NONSYN	235	237	GTT	401	403	ATT	15;15;16	A;T;T	15;15;16	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	518	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1069	25.9	0	.	p	.	0	R246G	NONSYN	736	738	AGA	902	904	GGA	23;23;24	G;G;A	23;23;24	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	518	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1069	25.9	0	.	p	.	0	S248P	NONSYN	742	744	TCG	908	910	CCG	24;24;25	C;C;G	24;24;25	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2478	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3049	43.6	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2250	2252	GAA	43;43;43	G;A;A	43;43;43	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2478	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3049	43.6	1	SNP	p	S83W	0	.	.	247	249	TCG	465	467	TCG	51;51;48	T;C;G	50;51;48	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2478	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3049	43.6	1	SNP	p	S83I	0	.	.	247	249	TCG	465	467	TCG	51;51;48	T;C;G	50;51;48	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2478	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3049	43.6	1	SNP	p	S83L	0	.	.	247	249	TCG	465	467	TCG	51;51;48	T;C;G	50;51;48	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2478	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3049	43.6	1	SNP	p	D87N	0	.	.	259	261	GAC	477	479	GAC	57;57;58	G;A;C	55;55;58	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2478	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3049	43.6	1	SNP	p	D87H	0	.	.	259	261	GAC	477	479	GAC	57;57;58	G;A;C	55;55;58	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2478	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3049	43.6	1	SNP	p	D87G	0	.	.	259	261	GAC	477	479	GAC	57;57;58	G;A;C	55;55;58	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2478	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3049	43.6	1	SNP	p	D87Y	0	.	.	259	261	GAC	477	479	GAC	57;57;58	G;A;C	55;55;58	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2478	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3049	43.6	1	SNP	p	D87V	0	.	.	259	261	GAC	477	479	GAC	57;57;58	G;A;C	55;55;58	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2516	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2841	47.6	1	SNP	p	R136C	0	.	.	406	408	CGC	625	627	CGC	54;55;55	C;G;C	54;54;54	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2516	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2841	47.6	1	SNP	p	R136L	0	.	.	406	408	CGC	625	627	CGC	54;55;55	C;G;C	54;54;54	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2516	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2841	47.6	1	SNP	p	R136H	0	.	.	406	408	CGC	625	627	CGC	54;55;55	C;G;C	54;54;54	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2516	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2841	47.6	1	SNP	p	R136G	0	.	.	406	408	CGC	625	627	CGC	54;55;55	C;G;C	54;54;54	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2516	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2841	47.6	1	SNP	p	R136E	0	.	.	406	408	CGC	625	627	CGC	54;55;55	C;G;C	54;54;54	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2516	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2841	47.6	1	SNP	p	R136S	0	.	.	406	408	CGC	625	627	CGC	54;55;55	C;G;C	54;54;54	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2516	gyrB_1	2415	2415	99.13	gyrB_1.l15.c4.ctg.1	2841	47.6	1	SNP	p	R136I	0	.	.	406	408	CGC	625	627	CGC	54;55;55	C;G;C	54;54;54	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	480	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1002	25.6	0	.	p	.	0	A72P	NONSYN	214	216	GCG	408	410	CCG	25;25;26	C;C;G	25;25;26	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	480	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1002	25.6	0	.	p	.	0	T123A	NONSYN	367	369	ACC	561	563	GCC	32;33;33	G,T;C;C	31,1;32;33	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	970	leuO	945	945	99.26	leuO.l6.c30.ctg.1	1353	38.6	0	.	p	.	0	P9S	NONSYN	25	27	CCA	191	193	TCA	43;42;45	T;C;A	43;42;45	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	322	marA	384	384	99.74	marA.l15.c4.ctg.1	821	21.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	190	marR	435	435	97.7	marR.l15.c4.ctg.1	734	13.8	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	493	495	AGC	16;15;13	A;G;C	16;15;13	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	190	marR	435	435	97.7	marR.l15.c4.ctg.1	734	13.8	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	595	597	CAT	8;8;8	C;A;T	8;8;7	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	190	marR	435	435	97.7	marR.l15.c4.ctg.1	734	13.8	1	SNP	p	V45E	0	.	.	133	135	GTG	319	321	GTG	30;30;31	G;T;G	30;30;31	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	190	marR	435	435	97.7	marR.l15.c4.ctg.1	734	13.8	1	SNP	p	I49S	0	.	.	145	147	ATC	331	333	ATC	29;29;29	A;T;C	29;29;29	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	190	marR	435	435	97.7	marR.l15.c4.ctg.1	734	13.8	1	SNP	p	A70T	0	.	.	208	210	GCA	394	396	GCA	22;22;22	G;C;A	22;22;21	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	190	marR	435	435	97.7	marR.l15.c4.ctg.1	734	13.8	1	SNP	p	R73S	0	.	.	217	219	CGT	403	405	CGT	20;20;19	C;G;T	19;20;19	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	190	marR	435	435	97.7	marR.l15.c4.ctg.1	734	13.8	1	SNP	p	R73C	0	.	.	217	219	CGT	403	405	CGT	20;20;19	C;G;T	19;20;19	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	190	marR	435	435	97.7	marR.l15.c4.ctg.1	734	13.8	1	SNP	p	R77C	0	.	.	229	231	CGC	415	417	CGC	15;15;15	C;G;C	15;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	190	marR	435	435	97.7	marR.l15.c4.ctg.1	734	13.8	1	SNP	p	R77L	0	.	.	229	231	CGC	415	417	CGC	15;15;15	C;G;C	15;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	190	marR	435	435	97.7	marR.l15.c4.ctg.1	734	13.8	1	SNP	p	L78M	0	.	.	232	234	CTG	418	420	CTG	15;15;15	C;T;G	15;15;14	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	190	marR	435	435	97.7	marR.l15.c4.ctg.1	734	13.8	1	SNP	p	R94S	0	.	.	280	282	CGC	466	468	CGC	12;12;12	C;G;C	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	190	marR	435	435	97.7	marR.l15.c4.ctg.1	734	13.8	1	SNP	p	R94H	0	.	.	280	282	CGC	466	468	CGC	12;12;12	C;G;C	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	190	marR	435	435	97.7	marR.l15.c4.ctg.1	734	13.8	1	SNP	p	V96E	0	.	.	286	288	GTA	472	474	GTA	12;13;14	G;T;A	12;13;14	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	788	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1441	28.9	0	.	p	.	0	S7F	NONSYN	19	21	TCC	37	39	TTC	3;3;3	T;T;C	2;3;3	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	788	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1441	28.9	0	.	p	.	0	R36I	NONSYN	106	108	AGG	124	126	ATC	14;13;13	A;T;C	14;13;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	788	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1441	28.9	0	.	p	.	0	E42A	NONSYN	124	126	GAA	142	144	GCC	2;2;5	G;C;C	2;2;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	788	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1441	28.9	0	.	p	.	0	N43V	NONSYN	127	129	AAT	145	147	GTG	6;6;6	G;T;G	6;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	788	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1441	28.9	0	.	p	.	0	E52D	NONSYN	154	156	GAG	172	174	GAT	12;12;12	G;A;T	12;12;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	788	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1441	28.9	0	.	p	.	0	N59T	NONSYN	175	177	AAC	193	195	ACC	13;13;13	A;C;C	13;13;13	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	788	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1441	28.9	0	.	p	.	0	I68L	NONSYN	202	204	ATA	220	222	TTA	12;12;11	T;T;A	12;12;11	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	788	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1441	28.9	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	361	363	CAG	54;54;53	C;A;G	54;54;53	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	788	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1441	28.9	0	.	p	.	0	D128A	NONSYN	382	384	GAC	400	402	GCC	39;39;40	G;C;C	39;39;40	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	788	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1441	28.9	0	.	p	.	0	S163A	NONSYN	487	489	TCG	505	507	GCG	35;34;36	G;C;G	34;34;34	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	788	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1441	28.9	0	.	p	.	0	L231V	NONSYN	691	693	CTT	709	711	GTT	18;18;18	G;T;T	11;16;17	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	788	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1441	28.9	0	.	p	.	0	R285fs	FSHIFT	853	853	C	871	871	C	31	C	30	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	806	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1572	27.4	0	.	p	.	0	V12trunc	TRUNC	34	34	G	249	249	G	30	G	30	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	806	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1572	27.4	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	306	308	CAG	19;22;22	C;A;G	19;22;22	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	806	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1572	27.4	0	.	p	.	0	T83I	NONSYN	247	249	ACC	456	458	ATC	24;22;20	A;T;C	23;22;20	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	806	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1572	27.4	0	.	p	.	0	I99M	NONSYN	295	297	ATA	504	506	ATG	12;12;13	A;T;G	12;12;13	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	806	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1572	27.4	0	.	p	.	0	A130T	NONSYN	388	390	GCC	597	599	ACC	26;26;25	A;C;C	26;26;25	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2830	mdtB	3123	3123	98.94	mdtB.l6.c30.ctg.1	3465	43.8	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1945	1947	ACC	74;77;78	A,C;C;C	73,1;77;78	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2830	mdtB	3123	3123	98.94	mdtB.l6.c30.ctg.1	3465	43.8	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2338	2340	CAA	33;34;34	C;A;A	31;33;32	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2830	mdtB	3123	3123	98.94	mdtB.l6.c30.ctg.1	3465	43.8	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2506	2508	ATT	32;32;32	A;T;T	32;30;31	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2830	mdtB	3123	3123	98.94	mdtB.l6.c30.ctg.1	3465	43.8	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2590	2592	GTT	36;36;38	G;T;T	36;36;38	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2830	mdtB	3123	3123	98.94	mdtB.l6.c30.ctg.1	3465	43.8	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2698	2700	GAG	29;32;30	G;A;G	29;31;30	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2830	mdtB	3123	3123	98.94	mdtB.l6.c30.ctg.1	3465	43.8	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2926	2928	ATG	25;26;26	A;T;G	25;25;26	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2830	mdtB	3123	3123	98.94	mdtB.l6.c30.ctg.1	3465	43.8	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3061	3063	GAT	26;27;29	G;A;T	26;26;29	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2360	mdtC	3078	3078	98.7	mdtC.l15.c30.ctg.1	3239	38.6	0	.	p	.	0	I46M	NONSYN	136	138	ATC	278	280	ATG	23;22;21	A;T;G	22;22;21	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2360	mdtC	3078	3078	98.7	mdtC.l15.c30.ctg.1	3239	38.6	0	.	p	.	0	V208I	NONSYN	622	624	GTC	764	766	ATC	38;40;39	A;T;C	38;40;39	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2360	mdtC	3078	3078	98.7	mdtC.l15.c30.ctg.1	3239	38.6	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3080	3082	CAC	4;4;4	C;A;C	4;4;4	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1080	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1827	31.7	0	.	p	.	0	D3E	NONSYN	7	9	GAT	154	156	GAA	13;12;12	G;A;A	13;12;12	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1080	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1827	31.7	0	.	p	.	0	T226A	NONSYN	676	678	ACG	823	825	GCG	43;43;43	G;C;G	43;43;43	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1080	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1827	31.7	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1165	1167	ATC	42;43;45	A;T;C	39;42;43	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1080	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1827	31.7	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1468	1470	TTT	49;49;47	T;T;T	49;49;47	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	539	1460	mdtE	1158	1158	99.22	mdtE.l15.c4.ctg.1	1598	49.1	0	.	p	.	0	A29T	NONSYN	85	87	GCC	280	282	ACC	38;38;39	A;C;C	37;38;38	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3386	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3578	50.8	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1091	1093	ACC	29;28;30	A;C;C	29;24;30	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3386	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3578	50.8	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2333	2335	GAC	70;69;70	G;A;C	68;68;69	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	998	mdtG	1227	1047	99.43	mdtG.l15.c30.ctg.1	1444	30.3	0	.	p	.	0	V200I	NONSYN	598	600	GTC	614	616	ATC	33;33;33	A;T;C	33;33;33	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	998	mdtG	1227	182	99.45	mdtG.l15.c30.ctg.2	551	17.3	0	.	p	.	0	E5G	NONSYN	13	15	GAA	205	207	GGA	12;12;11	G;G;A	12;12;11	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1018	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1654	33.1	0	.	p	.	0	G134C	NONSYN	400	402	GGT	676	678	TGT	56;56;55	T;G,A;T	56;55,1;55	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1018	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1654	33.1	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1246	1248	TTG	33;31;31	T;T;G	33;31;31	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1018	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1654	33.1	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1456	1458	ACG	14;15;15	A;C;G	14;15;15	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1212	mdtL	1176	1176	98.21	mdtL.l15.c4.ctg.1	1631	39.9	0	.	p	.	0	A185S	NONSYN	553	555	GCC	753	755	TCC	36;37;36	T;C;C	36;37;36	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	782	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1478	28.5	0	.	p	.	0	V119I	NONSYN	355	357	GTT	547	549	ATT	29;29;28	A;T;T	29;29;28	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1896	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2393	42.4	0	.	p	.	0	V11M	NONSYN	31	33	GTG	200	202	ATG	20;19;21	A;T;G	19;19;21	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1896	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2393	42.4	0	.	p	.	0	T33I	NONSYN	97	99	ACC	266	268	ATC	28;28;31	A;T;C	27;27;31	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1896	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2393	42.4	0	.	p	.	0	C116R	NONSYN	346	348	TGC	515	517	CGC	49;48;48	C;G;C	49;48;48	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1896	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2393	42.4	0	.	p	.	0	N238S	NONSYN	712	714	AAC	881	883	AGC	51;50;51	A;G;C	51;48;51	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1896	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2393	42.4	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1082	1084	GTG	39;39;40	G;T;G	39;39;39	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1896	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2393	42.4	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1145	1147	AAC	21;20;17	A;A;C	20;18;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1896	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2393	42.4	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1190	1192	GTC	35;35;37	G;T;C	32;35;37	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1896	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2393	42.4	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1220	1222	ATA	46;46;47	A;T;A	45;46;47	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1896	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2393	42.4	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1328	1330	TCT	33;35;34	T;C;T	32;34;33	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1896	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2393	42.4	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1715	1717	GCG	47;49;49	G;C;G	47;49;49	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1896	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2393	42.4	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1928	1930	ATC	34;34;34	A;T;C	34;33;34	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1174	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1805	34.8	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	386	386	T	62	T	61	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1174	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1805	34.8	0	.	p	.	0	S129A	NONSYN	385	387	TCA	569	571	GCG	35;36;37	G;C;G	35;35;37	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1174	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1805	34.8	0	.	p	.	0	A187T	NONSYN	559	561	GCC	743	745	ACC	29;30;29	A;C;C	29;30;29	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1174	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1805	34.8	0	.	p	.	0	H211R	NONSYN	631	633	CAC	815	817	CGC	52;52;53	C;G;C	52;52;53	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1174	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1805	34.8	0	.	p	.	0	V250A	NONSYN	748	750	GTT	932	934	GCT	34;37;38	G;C;T	34;37;38	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1174	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1805	34.8	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1016	1018	AAA	25;25;24	A;A;A	25;25;23	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1174	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1805	34.8	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1034	1036	CGA	28;29;30	C;G;A	28;29;30	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1174	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1805	34.8	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1199	1201	GCC	29;29;28	G;C;C	29;29;28	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1174	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1805	34.8	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1211	1213	GAT	33;35;35	G;A;T	32;34;33	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1174	mdtP	1467	1467	97.89	mdtP.l15.c4.ctg.1	1805	34.8	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1628	1630	GCT	11;9;9	G;C;T	11;9;9	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3096	mfd	3447	3447	99.16	mfd.l6.c4.ctg.1	3885	42.9	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1528	1530	AAG	46;47;47	A;A;G	46;47;47	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3096	mfd	3447	3447	99.16	mfd.l6.c4.ctg.1	3885	42.9	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2605	2607	CTG	45;46;43	C;T;G	45;46;43	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	190	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	340	21.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1778	msbA	1749	1749	98.68	msbA.l6.c30.ctg.1	2114	45.2	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1006	1008	AAC	37;39;40	A;A;C	37;39;40	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1778	msbA	1749	1749	98.68	msbA.l6.c30.ctg.1	2114	45.2	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1552	1554	ATA	41;41;39	A;T;A	40;41;39	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1464	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1636	48.2	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1294	1296	GAT	74;73;72	G;A;T	74;73;72	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1464	murA_12	1260	1260	98.57	murA_12.l15.c4.ctg.1	1636	48.2	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1297	1299	CTG	71;68;66	C;T;G	71;68;65	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1187	27.0	0	.	p	.	0	R27C	NONSYN	79	81	CGT	313	315	TGT	40;39;39	T;G;T	40;39;39	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1187	27.0	0	.	p	.	0	I117T	NONSYN	349	351	ATC	583	585	ACC	31;32;32	A;C;C,T	30;31;30,1	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1187	27.0	0	.	p	.	0	G187D	NONSYN	559	561	GGC	793	795	GAC	27;28;29	G;A;C	27;28;29	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1187	27.0	1	SNP	p	R15C	0	.	.	43	45	CGC	277	279	CGC	56;55;55	C;G;C	56;55;55	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1187	27.0	1	SNP	p	S33R	0	.	.	97	99	AGC	331	333	AGC	36;38;38	A;G;C	36;37;38	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1187	27.0	1	SNP	p	G131D	0	.	.	391	393	GGC	625	627	GGC	38;37;37	G;G;C	38;37;36	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1187	27.0	1	SNP	p	R203C	0	.	.	607	609	CGT	841	843	CGT	45;45;44	C;G;T	45;45;43	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1187	27.0	1	SNP	p	R203L	0	.	.	607	609	CGT	841	843	CGT	45;45;44	C;G;T	45;45;43	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1154	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1507	40.9	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1141	1143	GAG	44;47;46	G;A;G,T	44;47;45,1	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1154	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1507	40.9	1	SNP	p	G141E	0	.	.	421	423	GGT	628	630	GGT	59;58;59	G;G;T	59;58;59	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1154	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1507	40.9	1	SNP	p	G141D	0	.	.	421	423	GGT	628	630	GGT	59;58;59	G;G;T	59;58;59	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1154	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1507	40.9	1	SNP	p	R154D	0	.	.	460	462	CGT	667	669	CGT	57;58;58	C;G;T	57;58;58	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1154	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1507	40.9	1	SNP	p	R154A	0	.	.	460	462	CGT	667	669	CGT	57;58;58	C;G;T	57;58;58	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2586	parC_2	2259	2259	99.29	parC_2.l6.c30.ctg.1	2679	51.9	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1817	1819	TCG	73;72;73	T;C;G	71;71;73	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2586	parC_2	2259	2259	99.29	parC_2.l6.c30.ctg.1	2679	51.9	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2432	2434	AAC	37;38;38	A;A;C	37;38;38	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2586	parC_2	2259	2259	99.29	parC_2.l6.c30.ctg.1	2679	51.9	1	SNP	p	A85T	0	.	.	253	255	GCG	446	448	GCG	53;55;55	G;C;G	53;53;53	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2586	parC_2	2259	2259	99.29	parC_2.l6.c30.ctg.1	2679	51.9	1	SNP	p	D111H	0	.	.	331	333	GAT	524	526	GAT	46;46;46	G;A;T	46;46;46	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2586	parC_2	2259	2259	99.29	parC_2.l6.c30.ctg.1	2679	51.9	1	SNP	p	S129P	0	.	.	385	387	TCC	578	580	TCC	55;56;55	T;C;C	55;56;55	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	27	1704	parE_1	1893	1893	97.57	parE_1.l6.c30.ctg.1	2107	42.0	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1446	1448	GAT	65;64;63	G;A;T	65;64;63	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1504	patA	1380	1380	99.86	patA.l15.c17.ctg.1	1809	44.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1277	1279	GAT	50;50;50	G;A;T	50;50;50	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4806	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4465	57.9	1	SNP	p	V146F	0	.	.	436	438	GTT	642	644	GTT	59;60;61	G;T;T	59;60;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4806	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4465	57.9	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1743	1745	CAG	72;74;76	C;A;G	72;74;76	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4806	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4465	57.9	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1743	1745	CAG	72;74;76	C;A;G	72;74;76	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4806	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4465	57.9	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1782	1784	CAC	55;56;56	C;A;C	55;56;56	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4806	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4465	57.9	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1791	1793	CGT	54;52;50	C;G;T	54;52;50	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4806	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4465	57.9	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1791	1793	CGT	54;52;50	C;G;T	54;52;50	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4806	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4465	57.9	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1797	1799	TCC	49;47;46	T;C;C	49;47;46	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4806	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4465	57.9	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1803	1805	CTC	44;45;46	C;T;C	44;45;46	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4806	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4465	57.9	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1893	1895	ACC	78;80;80	A;C;C	78;80;80	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4806	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4465	57.9	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1896	1898	CCT	81;84;85	C;C;T	81;84;85	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	4806	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4465	57.9	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2265	2267	CGT	108;107;106	C;G;T	108;105;103	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	0	.	n	.	0	A226G	SNP	226	226	A	299	299	G	441	G	438	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	1	SNP	n	A794G	0	.	.	794	794	A	867	867	A	360	A	350	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	1	SNP	n	A794T	0	.	.	794	794	A	867	867	A	360	A	350	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	1	SNP	n	G926C	0	.	.	926	926	G	999	999	G	381	G	380	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	1	SNP	n	G926A	0	.	.	926	926	G	999	999	G	381	G	380	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	1	SNP	n	G926T	0	.	.	926	926	G	999	999	G	381	G	380	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	1	SNP	n	A1519C	0	.	.	1519	1519	A	1592	1592	A	236	A	231	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	1	SNP	n	A1519T	0	.	.	1519	1519	A	1592	1592	A	236	A	231	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	1	SNP	n	A1519G	0	.	.	1519	1519	A	1592	1592	A	236	A	231	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	0	HET	.	.	.	T90C	.	90	90	T	163	163	T	341	T,C	246,91	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	0	HET	.	.	.	A250T,G	.	250	250	A	323	323	A	378	A,T,G	277,96,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	0	HET	.	.	.	G474A	.	474	474	G	547	547	G	407	G,A	315,91	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	0	HET	.	.	.	A253T	.	253	253	A	326	326	A	377	A,T	278,95	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	0	HET	.	.	.	C194T	.	194	194	C	267	267	C	358	C,T	284,71	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	0	HET	.	.	.	C719T	.	719	719	C	792	792	C	309	C,T	180,128	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	0	HET	.	.	.	G1002A	.	1002	1002	G	1075	1075	G	338	G,A	208,130	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	0	HET	.	.	.	G1006C	.	1006	1006	G	1079	1079	G	335	G,C	207,121	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	0	HET	.	.	.	A79G	.	79	79	A	152	152	A	362	A,G	276,86	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	0	HET	.	.	.	C1038T	.	1038	1038	C	1111	1111	C	350	C,T	205,144	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	0	HET	.	.	.	T273A	.	273	273	T	346	346	T	345	T,A	248,92	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	0	HET	.	.	.	T1010C	.	1010	1010	T	1083	1083	T	332	T,C	209,115	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	12174	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1628	371.7	0	HET	.	.	.	C183T	.	183	183	C	256	256	C	335	C,T	221,112	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	532	soxR	465	465	100.0	soxR.l15.c17.ctg.1	814	35.1	1	SNP	p	R20H	0	.	.	58	60	CGC	225	227	CGC	61;60;57	C;G;C	60;59;56	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	532	soxR	465	465	100.0	soxR.l15.c17.ctg.1	814	35.1	1	SNP	p	G121D	0	.	.	361	363	GGT	528	530	GGT	59;59;60	G;G;T	59;58;60	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	370	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	764	26.0	1	SNP	p	A12S	0	.	.	34	36	GCA	226	228	GCA	41;40;39	G;C;A	41;40;39	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1764	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1901	49.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
